Global Cancer Early Detection Market Growth 2023-2029
The 2 components of early detection of cancer are early diagnosis (or downstaging) and screening. Early diagnosis focuses on detecting symptomatic patients as early as possible, while screening consists of testing healthy individuals to identify those having cancers before any symptoms appear.
LPI (LP Information)' newest research report, the “Cancer Early Detection Industry Forecast” looks at past sales and reviews total world Cancer Early Detection sales in 2022, providing a comprehensive analysis by region and market sector of projected Cancer Early Detection sales for 2023 through 2029. With Cancer Early Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cancer Early Detection industry.
This Insight Report provides a comprehensive analysis of the global Cancer Early Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cancer Early Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cancer Early Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cancer Early Detection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cancer Early Detection.
The global Cancer Early Detection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cancer Early Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cancer Early Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cancer Early Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cancer Early Detection players cover Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, Oncognostic and Epigenomics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Early Detection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Colorectal Cancer
Liver Cancer
Lung Cancer
Other
Segmentation by application
Hospital
Medical Center
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Exact Sciences
Grail
Genetron Health
New Horizon Health
Burning Rock
Berry Oncology
Shanghai Kunyuan Biotechnology
Oncognostic
Epigenomics
Abbott
Qiagen
iStat Biomedical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cancer Early Detection market?
What factors are driving Cancer Early Detection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cancer Early Detection market opportunities vary by end market size?
How does Cancer Early Detection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.